Alere Analytics Launches Hospital Clinical Surveillance Solution for Infection Control and Medication Management at the 40th Annual APIC Conference

Real-Time Recommendations, Patient Population Analytics and CDC Reporting Bolsters Patient Safety While Reducing Treatment Costs

<0> Schwartz MSLErin Zwirn, 781-684-0770 </0>

, an Alere subsidiary specializing in analytics and clinical decision support (CDS) technology, today announced the launch of its Clinical Surveillance product for hospitals, which is an automated technology solution designed to manage antimicrobial stewardship, infection control and medication management. Alere will demonstrate this new solution at the 40 Annual Conference of the Association for Professionals in Infection Control and Epidemiology (APIC), as well as showcase its antimicrobial stewardship initiative at booth #206. Test Target Treat™ demonstrates the importance of using rapid diagnostics to make more targeted treatment decisions and reduce the inappropriate use of antibiotics.

Alere’s new Clinical Surveillance Solution is currently being deployed at a large over 500- bed hospital in the greater New York area, which further strengthens Alere’s rapid diagnostics and real-time decision support footprint in over 2,000 hospitals. The Clinical Surveillance Solution provides a dashboard view of all patients currently being treated in order to provide clinicians with real-time information that can reduce the risk of hospital acquired infections. The platform’s single sign-on provides access and input data without requiring providers to sign on to another system, and can be easily integrated into existing hospital systems with no disruption to workflow. In addition, our flexible and evidence-driven rules editor help infection control personnel to prevent Healthcare-associated Infections (HAI), identify those at risk of new infections, take appropriate action in real-time, and prevent adverse events and readmissions.

“Antimicrobial resistance is a growing concern in the healthcare industry andeffectively managing clinical surveillance in any hospital or ICU is vital to ensuring patient safety and maintaining the highest quality of care,” said Dr. Fauzia Khan, FCAP and Chief Medical Officer of Alere Analytics. “Our new clinical surveillance solution automates infection control, medication management and health reporting to address the evolving needs of hospitals and health systems that are looking to improve health outcomes, boost patient satisfaction and satisfy regulatory reporting requirements to maximize their incentive payments.”

Alere Analytics’ integrated platform of real-time analytics and population management tools evaluates important patient information including anticoagulation and glycemic monitoring, IV to PO conversion, medication safety surveillance, and in turn, ensures patient safety while reducing costs such as treatments associated with inappropriate medication.It is designedto provide hospitals of any bed size with the ability to seamlessly capture and report on quality, performance and accountability measures from electronic health records (EHRs). The Clinical Surveillance Solution also provides electronic reporting capabilities to public health agencies such as the Centers for Disease Control. By automating these measures, hospitals will be able to save countless hours and resources, while providing the highest quality of care to their patients.

The Alere Analytics Clinical Surveillance Solution provides hospitals with real-time capabilities that support the following initiatives:

Alere Analytics’ platform is built on industry standards to provide both functional interoperability through HL7v3, as well as semantic interoperability across medical terminologies. The parameters of the system are defined by the hospital user and include a coordinated effort with infection control practitioners, pharmacists and laboratory personnel. The dashboard’s single view allows actionable information to be delivered in real-time and at the point of care, in order to directly and immediately impact and improve the quality of care for both the individual patient and entire populations. Most importantly, the evidence-based content is developed by Alere Analytics’ team of clinicians and sourced from today’s current healthcare guidelines.

If you would like more information about Alere Analytics’ new Clinical Surveillance Solution, please contact Roger Panduro at or Bill Behnke at . You can also , “ .”

Alere Analytics, formerly DiagnosisOne, provides the healthcare industry with unparalleled analytics and clinical decision support tools based on a single platform. The company’s analytics and decision support solution leverages the world's largest library of evidence-based medical knowledge and integrates seamlessly with existing hospital and laboratory information systems. It delivers intelligent and actionable information that ensures improved patient care, fewer errors and better clinical outcomes. Alere Analytics’ customers include hospitals, healthcare providers, payers, EHR companies, systems integrators and government entities. Based in Lowell, Mass., Alere Analytics was formed as DiagnosisOne in 2003 by a team of physicians and healthcare IT professionals. In July 2012, DiagnosisOne joined Alere, a leading provider of near-patient diagnostics and health information solutions, and is now conducting business as Alere Analytics. For more information about the Company and its solutions, visit .

By developing new capabilities in near-patient diagnosis, monitoring and health information technology, Alere enables individuals to take charge of improving their health and quality of life at home. Alere's global leading products and services, as well as its new product development efforts, focus on cardiology, infectious disease, toxicology and diabetes. Alere is headquartered in Waltham, Massachusetts. For more information regarding Alere, please visit .

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.